Pulse glucocorticoid therapy is used in hyperinflammation related to coronavirus disease 2019 (COVID-19). We evaluated the efficacy and safety of pulse intravenous methylprednisolone in addition to standard treatment in COVID-19 pneumonia.
Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial / Salvarani, C., Massari, M., Costantini, M., Merlo, D.F., Mariani, G.L., Viale, P., Nava, S., Guaraldi, G., Dolci, G., Boni, L., Savoldi, L., Bruzzi, P., Turrà, C., Catanoso, M., Marata, A.M., Barbieri, C., Valcavi, A., Franzoni, F., Cavuto, S., Mazzi, G., et al.. - In: EUROPEAN RESPIRATORY JOURNAL. - ISSN 0903-1936. - ELETTRONICO. - 60:(2022), pp. 1-10. [10.1183/13993003.00025-2022]
Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial
Boni, Luca;Cavuto, Silvio;Bartoloni, Alessandro;Zammarchi, Lorenzo;
2022
Abstract
Pulse glucocorticoid therapy is used in hyperinflammation related to coronavirus disease 2019 (COVID-19). We evaluated the efficacy and safety of pulse intravenous methylprednisolone in addition to standard treatment in COVID-19 pneumonia.
| File | Dimensione | Formato | |
|---|---|---|---|
|
2200025.full.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
546.7 kB
Formato
Adobe PDF
|
546.7 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
